TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $14,379,000 | – | 14,620,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arena Capital Advisors, LLC- CA | 68,443,000 | $68,785,000 | 10.97% |
| PIPER SANDLER & CO. | 12,550,000 | $12,425,000 | 8.95% |
| Radcliffe Capital Management, L.P. | 100,783,000 | $100,279,000 | 6.28% |
| INCOME RESEARCH & MANAGEMENT | 14,775,000 | $14,701,000 | 5.39% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,123,000 | 1.30% |
| Bracebridge Capital, LLC | 5,500,000 | $5,390,000 | 0.82% |
| Western Asset Management Company, LLC | 9,000,000 | $8,916,000 | 0.57% |
| WESTWOOD HOLDINGS GROUP INC | 43,125,000 | $42,856,000 | 0.49% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,050,000 | $1,045,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,675,000 | 0.35% |